Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) prevention, but its performance in different cancers remains uncertain
Background The Khorana score is a validated tool to identify cancer patients at higher risk of venou...
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events...
International audienceBackground:The Khorana score is a predictive risk model for venous thromboembo...
Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving c...
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events...
BACKGROUND: Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients...
The Khorana score is a clinical prediction score developed to identify ambulatory cancer patients at...
Background The Khorana score is a validated tool to identify cancer patients at higher risk of venou...
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events...
International audienceBackground:The Khorana score is a predictive risk model for venous thromboembo...
Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving c...
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events...
BACKGROUND: Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients...
The Khorana score is a clinical prediction score developed to identify ambulatory cancer patients at...
Background The Khorana score is a validated tool to identify cancer patients at higher risk of venou...
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events...
International audienceBackground:The Khorana score is a predictive risk model for venous thromboembo...